Does BOTULINUM TOXIN TYPE A Cause Hypercholesterolaemia? 435 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 435 reports of Hypercholesterolaemia have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 11.6% of all adverse event reports for BOTULINUM TOXIN TYPE A.
435
Reports of Hypercholesterolaemia with BOTULINUM TOXIN TYPE A
11.6%
of all BOTULINUM TOXIN TYPE A reports
434
Deaths
352
Hospitalizations
How Dangerous Is Hypercholesterolaemia From BOTULINUM TOXIN TYPE A?
Of the 435 reports, 434 (99.8%) resulted in death, 352 (80.9%) required hospitalization, and 359 (82.5%) were considered life-threatening.
Is Hypercholesterolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 435 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Hypercholesterolaemia?
ALENDRONATE (1,607)
METHOTREXATE (1,547)
TOCILIZUMAB (1,483)
ADALIMUMAB (1,479)
ABATACEPT (1,410)
RITUXIMAB (1,389)
PREDNISONE (1,377)
INFLIXIMAB (1,338)
DICLOFENAC (1,331)
LEFLUNOMIDE (1,322)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Hypercholesterolaemia Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE